Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Novartis

Olema Stock Has Soared 551% This Year. Its CEO Thinks It's Still Undervalued.

Olema Oncology is targeting two markets worth $15 billion with the attitude, "we punch above our weight," according to CEO Sean Bohen.

Investors Business Daily

We could see thunderstorm asthma in south-eastern Australia this season – here's how to prepare

Victorians have been warned to prepare for the possibility of thunderstorm asthma again this season.

The Conversation

Novartis Hikes Its Earnings Outlook For The Third Time This Year

Novartis stock inched higher Tuesday after the firm hiked its earnings outlook for the third time this year following its Sandoz spinoff.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Regeneron Hits A New Record High On The Approval That 'Could Not Come Soon Enough'

Shares of REGN stock jumped Monday after the FDA approved Regeneron Pharmaceuticals' high-dose Eylea following a delay this summer.

Investors Business Daily

Revealed: drug firms funding UK patient groups that lobby for NHS approval of medicines

Observer investigation shows that majority of Nice drug appraisals involve groups financially linked to maker of pharmaceuticals

The Guardian - UK

Dow Jones Futures Rise After Market Rallies On Microsoft AI Push; Netflix, Tesla Earnings On Tap

Microsoft AI pricing fueled the Nasdaq, which is increasingly extended. Netflix and Tesla earnings loom.

Investors Business Daily

Novartis Breaks Out After Putting Up Its Best Profit Growth In Two Years

Novartis stock broke out Tuesday after putting up its best profit growth in two years and raising its outlook for the year.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Drug Maker Novartis Stock Shows Rising Relative Strength

Novartis ADR shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

Panadol maker plans sweeping job cuts a year after being spun off from GSK

Exclusive: Consumer healthcare firm Haleon to cut hundreds of roles in UK and potentially thousands globally

The Guardian - UK

‘It’s naive to think this is in the best interests of the NHS.’ How Big Pharma’s millions are influencing healthcare

Observer investigation shows drug company money flows through the NHS, raising questions about conflict of interest

The Guardian - UK

Meet Chinook Therapeutics, The Company Novartis Is Spending $3.5 Billion To Acquire

Chinook wasn't looking to sell when Novartis approached. But the deal might be the best bet for patients — and KDNY stockholders.

Investors Business Daily

Congress ponders whether AI should have the power of the patent

Lawmakers are beginning to consider ways in which artificial intelligence systems are involved in inventive processes like discovery of new drugs, and how the use of such technologies affects what is, and is not, patentable.

Tribune News Service

Congress ponders whether AI should have the power of the patent - Roll Call

Lawmakers are beginning to consider ways in which artificial intelligence is involved in inventive processes like discovery of new drugs.

Roll Call

Chinook Therapeutics Launches Almost 60% On Novartis' $3.5 Billion Takeover

Novartis said Monday it would pay $3.5 billion to buy kidney disease-focused Chinook Therapeutics, and the biotech stock rocketed almost 60%.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Novartis Stock Hits Record High On A Trio Of First-Quarter Drivers

Novartis stock jumped early Tuesday on a trio of drugs that helped drive its first-quarter earnings report to a beat and raise.

Investors Business Daily

Dow Jones Holds Gains While Tech Off Lows; Tesla Gets Upgrade; Largest Crypto Exchange In Troubled Waters

Binance may have breached U.S. rules, including those related to anti-money laundering.

Investors Business Daily

Novartis Surges As It Goes After Eli Lilly's Second Biggest Moneymaker

Novartis stock surged Monday after the company's treatment reduced the risk of relapse in patients with early-stage breast cancer.

The Guardian - UK

Novartis scraps cholesterol drug trial in blow to UK life sciences ambitions

Swiss firm’s withdrawal from Leqvio trial with NHS dents government plans to attract post-Brexit research and investment

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Doctor with Stage 4 cancer is refused access to lifesaving treatment on the NHS

Dr Asha Umrawsingh, 50, was first diagnosed with breast cancer in 2010

Fortune

Over dinner in Davos, the CEOs of Novartis, Coca-Cola, and Grab shared what’s worrying them

Highlights from Fortune's dinner in Davos.

Investors Business Daily

Prime-Time Battles Drive GSK And Novo Nordisk In 2023; Novartis Preps Its Spinoff

GSK stock and NVO stock rose Wednesday, though both beat forecasts. Novartis stock skidded on lighter-than-expected sales.

Fortune

Coca-Cola and Novartis's CEOs don't care if 'ESG' has become a toxic phrase among some

It's about delivering on corporate missions in a sustainable way, they said at Davos.

StockNews.com

1 Large-Cap Stock You Should Purchase This Week

Pharmaceutical company Novartis (NVS) maintained its growth momentum in the third quarter of fiscal 2022, and the company’s growth prospects look promising, supported by its clear focus on five core therapeutic areas, having multiple significant in-market and pipeline assets. Given NVS’ reliable dividend payments and high profitability, this large-cap stock…

Investors Business Daily

Moderna Stock Breaks Out As Cancer Vaccine Shows Promise In Keytruda Tie-Up

Moderna unveiled promising results for its personalized cancer vaccine on Tuesday. The results sent Moderna shares soaring.

The Guardian - UK

I can’t get my HRT, again – this second UK shortage wasn’t supposed to happen

The government claims that supply issues have been tackled, but menopausal women know this is far from the truth, says author Rose George

1 2 3 4 5

People

Elon Musk

21,084 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations